U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C18H21NO2
Molecular Weight 283.3655
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of METHYL 3-(2-(BENZYL(METHYL)AMINO)ETHYL)BENZOATE

SMILES

CN(CCc1cccc(c1)C(=O)OC)Cc2ccccc2

InChI

InChIKey=IGJQEMHBYKNIQR-UHFFFAOYSA-N
InChI=1S/C18H21NO2/c1-19(14-16-7-4-3-5-8-16)12-11-15-9-6-10-17(13-15)18(20)21-2/h3-10,13H,11-12,14H2,1-2H3

HIDE SMILES / InChI

Molecular Formula C18H21NO2
Molecular Weight 283.3655
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Jun 26 11:13:22 UTC 2021
Edited
by admin
on Sat Jun 26 11:13:22 UTC 2021
Record UNII
BM2TE2XHK6
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
METHYL 3-(2-(BENZYL(METHYL)AMINO)ETHYL)BENZOATE
Common Name English
BENZOIC ACID, 3-(2-(METHYL(PHENYLMETHYL)AMINO)ETHYL)-, METHYL ESTER
Systematic Name English
M-(2-(BENZYLMETHYLAMINO)ETHYL)BENZOIC ACID METHYL ESTER
Common Name English
PRL-8-53 FREE BASE
Code English
Code System Code Type Description
PUBCHEM
39989
Created by admin on Sat Jun 26 11:13:22 UTC 2021 , Edited by admin on Sat Jun 26 11:13:22 UTC 2021
PRIMARY
FDA UNII
BM2TE2XHK6
Created by admin on Sat Jun 26 11:13:22 UTC 2021 , Edited by admin on Sat Jun 26 11:13:22 UTC 2021
PRIMARY
CAS
51352-88-6
Created by admin on Sat Jun 26 11:13:22 UTC 2021 , Edited by admin on Sat Jun 26 11:13:22 UTC 2021
PRIMARY
WIKIPEDIA
PRL-8-53
Created by admin on Sat Jun 26 11:13:22 UTC 2021 , Edited by admin on Sat Jun 26 11:13:22 UTC 2021
PRIMARY PRL-8-53 is relatively non-toxic, with an oral LD50 in mice of 860 mg/kg, giving the drug a high therapeutic index. Doses above 8 mg/kg have brief hypotensive effects in the canine. High doses depress motor activity in the rat and mouse, with the ED50 for a 50% reduction in motor activity of mice at 160 mg/kg. PRL-8-53 displays spasmolytic effects.
MANUFACTURER PRODUCT INFORMATION
PRL-8-53
Created by admin on Sat Jun 26 11:13:22 UTC 2021 , Edited by admin on Sat Jun 26 11:13:22 UTC 2021
PRIMARY The only human study on PRL-8-53 was based on the ingestion of a single 5 mg dose. There is no data on the effectiveness or potential toxicity of any other dosage in humans.
Related Record Type Details
SALT/SOLVATE -> PARENT
PARENT -> DERIVATIVE
PARENT -> DERIVATIVE
Related Record Type Details
ACTIVE MOIETY
For freebase form